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Abstract 
Introduction: The effects of Jin-Ying-Tang (JYT) on Toll-like Receptor 4 (TLR4) signalling transduction of 
lipopolysaccharide (LPS)-stimulated mouse mammary epithelial cells (MECs) in vitro were examined. Material and Methods: 
The cytotoxicity of JYT (0.06-62.50 mg/mL) on mouse MECs was determined by MTT assay. The MECs were co-cultured with 
LPS in the presence or absence of JYT (39.10 μg/mL, 391 μg/mL, 3910 μg/mL). The concentrations of interleukin-6 (IL-6) and 
tumour necrosis factor-α (TNF-α) in the culture supernatants were detected by ELISA. The mRNA expression of TLR4 and 
downstream TLR4 signalling molecules such as myeloid differentiation factor 88 (MyD88), tumour necrosis factor receptor 
associated factor 6 (TRAF-6), inhibitor κB (IκB), and nuclear factor κB inducing kinase (NIK) were determined by quantitative 
real-time polymerase chain reaction (qRT-PCR). Results: The results showed that the IC50 of JYT on MECs was 12.25 mg/mL 
and JYT could significantly decrease the concentrations of IL-6 and TNF-α in LPS-stimulated MECs (P < 0.05). The mRNA 
expression of TLR4, MyD88, TRAF-6, IκB, and NIK was also significantly decreased when the LPS-stimulated MECs were co-
cultured at appropriate concentrations of JYT (P < 0.05, P < 0.01). Conclusion: These observations indicate a potential 
mechanism through which JYT attenuates the systemic inflammatory response to LPS-stimulated mouse mammary epithelial 
cells by inhibiting the activation of TLR4/MyD88/ TRAF-6/NIK pathway at the mRNA level.  
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Introduction 
Mastitis is one of the most epidemic, frequent, and 
costly infectious diseases affecting the dairy cattle 
industry worldwide. It is an infection of the udder 
caused by a variety of different bacteria and fungi (such 
as Staphylococcus aureus, coliforms) entering the 
mammary gland via the teat canal (3). During the 
incidence of mastitis, mammary gland immunity plays 
an important role in the prevention of microbial 
invasion, as the first line of defence. Mammary 
epithelial cells (MECs) together with macrophages are 
capable to respond to bacterial intrusion and play  
a major part in the initiation of inflammation (32).  
A key component of the host innate immune response 
to mastitis is a rapid increase in concentrations of 
cytokines, such as IL-6, IL-8, IL-1β, and TNF-α in 
milk. These cytokines can attract neutrophils to the site 
of infection and provide defence against invading 
mastitis pathogens (22, 23). Stimulation of bovine 
MECs with LPS for 24 h elicited a marked increase in 
mRNA expression of IL-1β, IL-6, TNF-α, CXCL6, and 
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β-defensin. Furthermore, differential cytokine and 
chemokine responses of bovine MECs to lipoteichoic 
from Staphylococcus aureus and LPS from Escherichia 
coli (7, 16, 27) indicate that MECs play an important 
role in the mammary gland immunity. 
Toll-like receptors (TLRs) are members of the 
pattern-recognition receptors family that detect specific 
molecules associated with microbial pathogens. Their 
activation leads to the mobilisation of other innate 
immune molecules such as cytokines, chemokines, and 
interferons (2, 19). TLRs activate signalling through 
the Toll/interleukin-1 receptor (TIR) domain, which in 
turn triggers the binding of the TIR domain-containing 
adaptors, including MyD88, TIR domain containing 
adaptor protein (TIRAP), TIR domain-containing 
adapter-inducing IFN-β (TRIF), and Trif-related 
adaptor molecule (TRAM), activating specific 
signalling pathways (13, 20). MyD88 activates the IL-1 
receptor associated kinases (IRAKs). IRAKs in turn 
activate TRAF-6, and elicit downstream signalling via 
the nuclear factor κB (NF-κB) pathway (36). TLR4 is  
a prominent member of the TLR family of host 
receptors (1, 18). LPS, a major component of the cell 
wall of Gram-negative bacteria, is able to bind to 
TLR4, resulting in activation of the transcription factor 
NF-κB via signal transduction cascades. MyD88- and 
TRAF-6-deficient mice display hyporesponsiveness to 
both IL-1 and LPS (14, 17). Finally, NF-κB is then free 
to translocate to the nucleus and induces the expression 
of various pro-inflammatory cytokines (such as TNF-α, 
IL-1β, IL-6, and IL-8) (6).  
Nowadays, development of antibacterial and 
immunomodulatory potential of natural products to 
replace the application of antibiotics in bovine mastitis 
have become mainstream in the prevention of mastitis 
in modern dairy industry (3, 26). Jin-Ying-Tang (JYT) 
is an empirical formula that was developed based on 
the principles of traditional Chinese medicine (TCM) 
and is used to treat mastitis in dairy cattle. This formula 
has obtained a national invention patent (Patent no.: ZL 
2010 1 0554152.8). JYT consists of the following 
herbs: macranthoides Hand.-Mazz., flower; Taraxacum 
mongolicum Hand.-Mazz., whole plant; Trichosanthes 
kirilowii Maxim., fruit; Forsythia suspensa (Thunb.) 
Vahl., fruit; Rheum officinale Baill., root; Astragalus 
membranaceus（Fisch.） Bunge., root; and the root of 
Angelica sinensis (Oliv. ） Diels., which have all  
been proven to possess many biological activities, 
including anti-inflammatory, immunomodulatory, and 
antibacterial properties (34, 35). We have reported that 
the cure rate and the effective rate of the JYT injection 
in subclinical mastitis in dairy cattle were 53.8% and 
92.3% respectively (30). JYT injections also exhibited 
favourable efficacy in Staphylococcus aureus-induced 
mastitis in rabbits and significantly decreased the  
TNF-α and IL-6 concentrations in serum and mammary 
glands (31). However, the precise mechanism of its 
anti-inflammatory activity remains largely unclear. 
Therefore, in this study, we have evaluated the effect of 
JYT on LPS-induced inflammation in MECs and its 
underlying anti-inflammatory mechanism from the 
perspective of  LPS-TLR4/ NF-κB signalling pathway, 
such as the expression of TLR4, MyD88, TRAF-6, 
IκB, and NIK, hoping to provide a theoretical basis for 
further research on JYT and its application in 
prevention or therapy of mastitis.  
Material and Methods 
Reagents and instruments. Mouse TNF-α and 
IL-6 ELISA kits were purchased from IBL, Germany. 
Power SYBR Green PCR Master Mix - from AB, UK, 
and FCS were acquired from Zhejiang Tianhang, 
China. TIANScript cDNA kit was purchased from 
Beijing TIANGEN, China. RNA extraction kit, EsTaq 
MasterMix, was procured from Beijing Kangwei, 
China. The qTOWER 2.0/2.2 Real Time PCR System  
was made in Analytic Jena AG, Germany.  
Thermo Scientific Multiskan™ GO Microplate 
Spectrophotometer was made in Thermo Fisher 
Scientific Oy, Finland, and IX-71 inverted phase 
contrast microscope in Olympus, Japan. 
Animals. Ten to 12-week-old, mid-pregnant 
Kunming mice were used. The mice were purchased 
from the Medical Experimental Animal Centre of 
Daping Hospital, Research Institute of Surgery of the 
Third Military Medical University, Chongqing. They 
were housed in micro isolator cages, receiving standard 
laboratory animal feed and water ad libitum. The 
experiments followed the guidelines of the regional 
Animal Ethics Committee. 
Chemicals. The herbs used in this study were all 
commercially available as dry matter and were 
purchased from Guizhou Tongjitang Zhongyaoyinpian 
Pharmaceutical Co. (Table 1). These herbs were 
identified by professor Lu Wu (Centre of Biochemical 
Engineering of Guizhou University, Guizhou, China) 
and professor Hua-Lei Wang (College of Agriculture of 
Guizhou University, Guizhou, China). The dosages of 
the herbs in JYT are based on the theory of Chinese 
Materia Medica (CMM) (5). 
Preparation of JYT. In total, 440 g of the 
formulation was soaked in 4400 mL of 50% alcohol for 
30 min and extracted two times under reflux for 2 h and 
1 h. The extracts were filtered and the filtrate was 
evaporated using a rotary evaporator to remove alcohol. 
The remains were further extracted by ligarine, and the 
aqueous phase was concentrated to 2.0 g of crude drug 
per millilitre. The concentrate was precipitated with 
70%, 75%, and 80% alcohol dilutions and then boiled 
with 0.125% active charcoal for 5 min and filtered. The 
precipitates were dissolved and diluted in 0.9% saline 
solution containing 1.0 g crude drug per millilitre of 
solution. The final concentration of JYT crude drug 
was 1.0 g/mL. The solution was filtered through  
a 0.22 μm microhole filtering film and stored at 4°C as 
JYT preparation (31).  
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Table 1. Information regarding the herbs 







Lonicerae macranthoides Hand.-Mazz., flower 
Taraxacum mongolicum Hand.-Mazz., whole plant 
Trichosanthes kirilowii Maxim., fruit 
Forsythia suspensa (Thunb.) Vahl., fruit 
Rheum officinale Baill., root 
Astragalus membranaceus（Fisch.） Bunge., root 
Angelica sinensis（Oliv.）Diels., root 
Shan yin hua 





























Furthermore, bacterial endotoxin in JYT was 
determined by rabbit pyrogen test. The endotoxin, 
conforming to injection quality standards, did not 
induce pyrogen reaction in rabbits (4). 
Primary culture of MECs. The procedure for 
primary culture of MECs has been previously described 
(8). In brief, mammary tissue was isolated from mid-
pregnancy mice, and epithelial cells were obtained after 
mixed protease digestion of the tissue. The epithelial 
organoid suspension was treated with differential 
adhesion method and then resuspended in a growth 
medium consisting of DMEM/F12, 10% FBS,  
100 IU/mL of penicillin, 100 IU/mL of streptomycin 
(Gibco), 4 mM L-glutamine (Sigma), 5 μg/mL of 
bovine pancreatic insulin (Sigma), 10 ng/mL of cholera 
toxin (Sigma), and 10 ng/mL of epidermal growth 
factor (Sigma). The medium was changed once every 
24 h. 
MTT assay for cytotoxicity of JYT. MTT assay 
for the monolayer culture was carried out according to 
the method by Mosmann (21), while the assay for the 
cytotoxicity of JYT on MECs cultures was performed 
with slight modification to the standard protocol.  
The cell concentration of MECs was adjusted to  
5 × 104 cell/well and then transferred into 96-well plate 
for culturing for 12 h. JYT was prepared as 11 
concentrations to be added to wells (0.06- 
62.50 mg/mL); each concentration was in duplicate. In 
each plate, four wells to which JYT was not added 
served as control. MECs were treated with different 
concentrations of JYT for 24 h. Subsequently, 20 µL of 
MTT solution (5 mg/mL) were added to each well and 
incubated for 4 h. After washing the supernatant out, 
the insoluble formazan product was dissolved in 
DMSO. The optical density of the 96-well culture 
plates was then measured at 490 nm absorption 
wavelength. The optical density of formazan formed in 
untreated control cells were used to indicate 100% 
viability. The concentrations of JYT that resulted in 
50% of cell death (IC50) in both monolayer cultures 
were determined from dose-response curves (9). The 
assay was carried out with four replicates for each 
culture. 
Cytokine measurement by ELISA. To assess  
the effect of JYT on the content of IL-6 and  
TNF-α secreted by MECs, the cells suspension  
(1 × 105 cell/well) was added into 48-well plate, and 
incubated with JYT and 10 μg/mL of LPS for 24 h. 
According to the result of cytotoxicity assay, the final 
concentrations of JYT were set as 3910 μg/mL,  
391 μg/mL, and 39.10 μg/mL. Control cells were 
treated with LPS alone. At the end of the experiment, 
culture supernatants were collected following 
centrifugation of the cell culture media and the levels 
of IL-6 and TNF-α were measured using cytokine-
specific ELISA kits according to producers’ 
instructions. All samples were assayed in triplicates. 
Absorbance was read at 450 nm. 
qRT-PCR. To determine the effect of JYT on 
mRNA expression of TLR4, MyD88, TRAF-6, IκB, 
and NIK in MECs, 500 μL of MECs suspension was 
added into a 24-well plate. When the cells completely 
spread out and grew to 80% confluence, 500 μL of JYT 
and/or LPS were added to the MECs. After 24 h 
incubation, each group of MECs was harvested and the 
RNAs were isolated following the manufacturer’s 
instruction. All of the RNAs were reverse transcribed 
by real-time PCR kit, and resulting cDNA was stored at 
-80ºC until amplification. 
All primers (Table 2) used in this study were 
designed with the software ‘Primer Premier 5.0’ using 
available mouse sequences (NCBI). Relative quantities 
of gene transcripts were measured by qPCR using the 
SYBR Green I fluorophore. Two microlitres of each 
cDNA template were amplified in a 10 μL of reaction 
volume at the following conditions: preheating at 95ºC 
for 5 min, followed by 40 cycles of denaturation at 
95ºC for 30 s, annealing at 59.4ºC (TLR4), 59.1ºC 
(IκB), or 60.5ºC (MyD88, TRAF-6 or NIK) for 30 s, 
and extension at 72ºC for 30 s, and then final extension 
at 72ºC for 2 min. For quantitative evaluation of gene 
expression, TLR4, MyD88, TRAF-6, IκB, and NIK 
mRNA levels were normalised to Gapdh mRNA by the 
2-∆∆Ct method (24, 25). 
Statistical analyses. The quantitative data are 
expressed as the mean ± standard deviation (± SD). 
Multiple means were compared using one-way analysis 
of variance, the least significant difference method was 
applied when the variance was equal; and Dunnett's T3 
test was performed when the variance was not equal. 
All of statistical analyses were performed using SPSS 
software 17.0 for Windows; differences with P < 0.05 
were considered statistically significant. 
Results 
Cytotoxicity of JYT in MECs. To confirm JYT’s 
safe dosage range in MECs, its effect on MECs 
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viability was determined using the MTT assay. As 
shown in Fig. 2, the cell viability was not affected by 
the treatment with the concentration of 0-3.91 mg/mL 
of JYT; the cells spread out completely and a confluent 
monolayer of cobblestone shape was well-distributed 
and had good refraction (Fig. 1A). However, the cell 
viability in the concentration of 7.81-62.50 mg/mL of 
JYT was decreased, the cells were smaller than in the 
lower dose group, and their shapes became round and 
shrunken; the transmittance turned weaker and darker, 
the gaps among cells became larger than normal, and 
some fragments of the cells were seen (Fig. 1B). The 
IC50 of JYT on MECs that was calculated from dose–
response curves was equal to 12.25 mg/mL, suggesting 
that the range of 39.10-3910 μg/mL JYT was safe to 
MECs. 
Effects of JYT on LPS-induced secretion of  
IL-6 and TNF-α in MECs. Since the release of 
cytokines is considered to constitute an indicator of 
inflammatory response, the effect of JYT on LPS-
induced inflammation in MECs was evaluated by 
measuring the secretion level of pro-inflammatory 
cytokines: TNF-α and IL-6. As shown in Fig. 3, LPS 
stimulation significantly induced the release of IL-6 
and TNF-α in MECs. However, JYT treatment 
significantly, both concentration-dependently and 
concentration-independently, reduced the LPS-induced 
secretion of IL-6 (Fig. 3A) and TNF-α (Fig. 3B), 
indicating that JYT may inhibit inflammation in MECs. 
Combined with MTT results, the possibility that the 
anti-inflammatory activity of JYT was due to its 
cytoxicity could be excluded. 
Effects of JYT on LPS-induced mRNAs 
expression of TLR4, MyD88, TRAF-6, IκB, and 
NIK in MECs. To investigate the mechanism of JYT 
anti-inflammatory activity, the mRNA expression of 
TLR4, MyD88, TRAF-6, IκB, and NIK was examined 
in mouse MECs. As shown in Fig. 4, upon LPS 
stimulation, mRNA expressions of TLR4, MyD88, 
TRAF-6, and NIK in MECs were markedly increased 
except IκB. This increase was significantly attenuated 
by JYT in both concentration-dependent and 
independent manner; however, IκB was further 
significantly decreased. All the results demonstrated 
that JYT prevented LPS-induced inflammatory 
response in MECs by inhibiting TLR4/MyD88/TRAF-
6/NIK signalling pathway (non-canonical NF-κB 
pathway) at the mRNA level; however, these results 
need further verification on the protein level.  
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Fig. 1. A. Four-days in vitro culture of mouse MECs (×200); cells spread out completely and a confluent monolayer 
of cobblestone shape was well-distributed and with good refraction. B. After 12 h incubation with 31.25 mg/mL 
JYT, the living cells were round, and part of cells was disrupted or incomplete 
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Fig. 2. Viability of the monolayer cultures of MECs determined from the MTT assay. Monolayer cultures of MECs were 
exposed to indicated concentrations of JYT for 24 h. MTT assay was performed in accordance with the original method. The 
data were normalised to the viability of control cells. Data are presented as average with SD (error bars) from at least three 
















































Fig. 3. Influence of JYT on IL-6 (A) and TNF-α (B) secretion by mouse MECs treated with LPS. 
Contents of IL-6 and TNF-α were measured (n = 4) in the culture supernatants by ELISA. Data are 
presented as mean ± SD of two independent experiments. * P < 0.05, ** P < 0.01, in comparison with 
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Fig. 4. Influence of JYT on the mRNAs expression of TLR4 (A), MyD88 (B), TRAF-6 (C), IκB (D), and NIK 
(E) of each group of treatment. The results were obtained according to the systems of housekeeping gene 
Gapdh. The mRNAs of TLR4, MyD88, TRAF-6, IκB, and NIK were measured in all groups (n = 3). Data are 
presented as mean ± SD of two independent experiments. ** P < 0.01, in comparison with control group. 




According to the theory of CMM (5), Lonicerae 
macranthoides Hand.-Mazz., Taraxacum mongolicum 
Hand.-Mazz., Rheum officinale Baill., Forsythia 
suspensa (Thunb.) Vahl. can clear away heat and 
toxic materials; Trichosanthes kirilowii Maxim., 
Astragalus membranaceus (Fisch.) Bunge. subdue 
inflammatory swelling and relieve stagnant “Qi” and 
“Blood”; Rheum officinale Baill., Angelica sinensis 
(Oliv.) Diels. can regulate and promote blood flow. 
All of these effects are beneficial in the treatment of 
mastitis and subcutaneous swelling abscesses in TCM. 
To support the traditional use of JYT, many studies on 
the activities of these herbs have been performed. It 
has been reported that the combination of Dandelion 
(Taraxacum mongolicum Hand.-Mazz., whole plant; 
Lonicera japonia Thunb., flower; Forsythia suspensa 
(Thunb.) Vahl.; fruit of Salvia miltiorrhiza Bge.; 
baicalin of Scutellaria baicalensis Georgi.) can all be 
effective against the swelling of the auricle caused by 
xylene, having a good effect in the treatment of 
clinical mastitis (cure rate 48.39%, effective rate 
77%); it also has an excellent effect on subclinical 
mastitis (cure rate 70.96%) (10). Taraxacum 
mongolicum Hand.-Mazz. shows anti-inflammatory 
activity through the inhibition of TNF-α and IL-1 
production, and COX-2 expression (15). Lonicerae 
macranthoides Hand.-Mazz. is a safe and mild anti-
inflammatory agent for treating various inflammatory 
disorders. Its different extracts can inhibit arachidonic 
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inflammatory cytokines expression (12, 29) in 
inflammatory model in vitro or in vivo. These findings 
suggest that JYT has potential benefits for TLR4 
signalling of LPS-induced MECs. 
       In our study, we preliminarily determined 
the appropriate concentration ranges of JYT by 
microscopic cytopathic observation and MTT assay. 
The safe concentration of JYT was 0.49 mg/mL and 
the IC50 of JYT was 12.25 mg/mL. According to the 
regression curves estimated from the data, the high 
dose group, the middle dose group, and the low dose 
group of JYT was designated as 3910 μg/mL,  
391 μg/mL, and 39.10 μg/mL, respectively. The 
subsequent experiments were conducted on the basis 
of the three concentration gradients of JYT. In 
addition, the effect of 10 μg/mL LPS on cell viability, 
permeability of cell membrane, and cell morphology 
was determined, and the results indicated that it had 
no effect on the above parameters (the data was not 
reported in this research). 
Nowadays, available data indicate that MECs are 
able to release neutrophil-mobilising chemokines  
and pro-inflammatory cytokines upon bacterial 
stimulation, which plays a significant role in the 
occurrence and progression of mastitis (23, 27, 33). 
The release of pro-inflammatory cytokines is 
therefore considered to constitute an indicator of the 
inflammatory response. MECs could be induced to 
secrete IL-1β, IL-6, IL-8, and TNF-α. This was found 
by Pareek et al. (23) and Wellnitz and Kerr (33). In 
our previous laboratory study (8), we found that 
mouse MECs can respond to the presence of LPS  
(10 μg/mL) and significantly up-regulate the release 
of TNF-α and IL-6. Using the LPS-stimulated 
infection model, we investigated the effect of JYT 
addition to the LPS-stimulated culture on production 
of TNF-α and IL-6. The results suggested that 
appropriate concentrations of JYT could down-
regulate the secretion of TNF-α and IL-6, which 
demonstrates that JYT could inhibit the inflammatory 
response in MECs. 
We have also demonstrated that LPS can mediate 
TLR4 signalling in MEC, leading to the production of 
TNF-α and IL-6 (8). In TLRs signalling pathway, 
TLR4 specifically recognises LPS, and forms LPS-
TLR4 complex, which results in initiating 
intracellular signalling pathway, including the 
activation of MyD88 and TRAF-6, and NF-κB. 
Finally, it mediates the release of pro-inflammatory 
cytokines (TNF-α and IL-6). NF-κB is a critical 
transcription factor for the release of cytokines. Both 
the canonical (IĸB activation) and non-canonical 
(NIK activation) nuclear factor-κB (NF-κB) signalling 
pathways could mediate the nuclear translocation of 
NF-κB (6, 28). In the canonical NF-κB pathway, NF-
κB in unstimulated cells is sequestered in the cytosol 
via interaction with inhibitory IκB proteins, when 
cells receive pathological stimuli. IκB proteins  
 
are phosphorylated by IκB kinase (IKK) and 
phosphorylation of IκB proteins results in their 
ubiquitination and degradation, which subsequently 
releases sequestered NF-κB, leading to its 
translocation to the nucleus. In the non-canonical NF-
κB pathway, NIK, together with a downstream  
kinase, inhibitor of NF-κB kinase α (IKKα),  
induces phosphorylation-dependent ubiquitination and 
processing of p100 and generates its respective 
mature proteins, p50 and p52, which results in the 
nuclear translocation of sequestered NF-κB members. 
Finally, both pathways induce the expression of 
various pro-inflammatory cytokines (such as TNF-α, 
IL-1β, and IL-6 ). 
In order to determine which changes of gene 
expression influence NF-κB nuclear translocation in 
LPS-induced MECs, and whether JYT exerts an effect 
on the expression of these genes, the mRNA 
expression of TLR4, MyD88, TRAF-6, IκB, and NIK 
was determined. The results indicated that the 
treatment of MECs with LPS can directly contribute 
to a significant increase in TLR4, MyD88, TRAF-6, 
and NIK mRNA, except IκB, which was significantly 
down-regulated. These findings were consistent with 
previously published data (11, 37). Furthermore, 
appropriate concentrations of JYT could inhibit the 
increase in TLR4, MyD88, TRAF-6, and NIK 
expression in MECs stimulated with LPS. 
Surprisingly, we found that JYT could not up-regulate 
but further inhibit the expression of IκB mRNA, 
which we had not expected. Generally, only increase 
in IκB expression may inhibit the release of NF-κB 
from the IκB complex and further reduce the cytokine 
(TNF-α and IL-6) production. Thus, it is possible that 
JYT attenuates LPS-induced NF-κB nuclear 
translocation in MECs and inhibits its action. 
However, the mRNA expression of NIK was down-
regulated, which means that the content of NIK 
protein would be decreased and could further inhibit 
ubiquitination and processing vitiation of 
TLR4/MyD88/TRAF-6/NIK pathway (nocanonical 
NF-κB pathway), but not TLR4/MyD88/TRAF-6/IκB 
pathway (canonical NF-κB pathway). Both pathways 
are directly or indirectly contributing to blocking 
further intracellular signalling pathways. Finally, it 
suppresses the activation of the NF-κB signalling 
pathway and further inhibits the release of TNF-α  
and IL-6. 
In the present study we preliminarily 
demonstrated that JYT attenuates the inflammatory 
response by inhibiting the activation of 
TLR4/MyD88/TRAF-6/NIK pathway at the mRNA 
level. This will lay a foundation for further research 
on the molecular mechanisms of JYT actions at the 
protein level. Our results also suggest that JYT may 
be a useful agent for preventing the release of 
cytokines in MEC, which plays a vital role in the 
development of mastitis. Further studies will be  
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conducted to better understand those key responses in 
order to propose new vaccinal or therapeutic 
strategies against mastitis. 
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